Gavin Low

22PUBLICATIONS
36CO-AUTHORS
Metabolic medicinePredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisNeurosciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jun 26, 2026
Summary of Guidelines for Identifying and Risk-Stratifying Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Primer for Family Physicians.

|Mar 19, 2026
Further Discussion of Differences in Imaging-based Investigations for Risk Stratification of Patients with MASLD Is Warranted.

Mitchell P Wilson, Gavin Low

|Mar 03, 2026
MRI features and LI-RADS categorization of combined hepatocellular-cholangiocarcinoma: a scoping review with prognostic implications.

Xu Jing Qian, Ali Ramji, Karim Samji

|Jan 28, 2026
An Updated Review of Combined Hepatocellular Cholangiocarcinoma: A Rare and Poorly Understood Neoplasm.

Gavin Low, Xu Jing Qian, Ali Ramji

|Jan 28, 2026
Not All Patients Need a CT When the Appendix Is Not Seen on Ultrasound: A Scoping Review.

Ali Ramji, Justin J Y Kim, Gavin Low

|Aug 06, 2025
Part 1: CAR Metabolic Dysfunction-Associated Steatotic Liver Disease Working Group Guidance Statements for Detecting and Grading Hepatic Steatosis Using Ultrasound, CT, or MRI.

Mitchell P Wilson, An Tang, Gavin Low

Pageof 4

Frequent Collaborators

13 joint publications

Mitchell Patrick Wilson

9 joint publications

Rishi Philip Mathew

9 joint publications

Vimal Patel

5 joint publications

Timothy Alexander